Welcome to our dedicated page for Veeva Systems news (Ticker: VEEV), a resource for investors and traders seeking the latest updates and insights on Veeva Systems stock.
Veeva Systems Inc. (NYSE: VEEV) is a global leader in cloud-based software solutions specifically tailored for the life sciences industry. Headquartered in the San Francisco Bay Area, Veeva Systems provides innovative technology that helps pharmaceutical and biotech companies streamline their operations, ensure compliance, and bring products to market faster. Veeva's product offerings address key operational and regulatory needs, ranging from customer relationship management (CRM) to content management and data analytics.
Two of the company's flagship products include Veeva CRM and Veeva Vault. Veeva CRM is designed for companies with a salesforce, providing tools to manage customer interactions more efficiently. Meanwhile, Veeva Vault is a versatile content management platform that supports various functions such as clinical trials, regulatory submissions, and quality management within life sciences companies.
Veeva serves a diverse customer base, ranging from emerging biotechs to some of the world's largest pharmaceutical companies. Its commitment to product excellence, customer success, and continuous innovation is evident as Veeva frequently updates its offerings to meet the evolving needs of the industry. Recently, Veeva announced that Boehringer Ingelheim has selected Veeva Vault Clinical and Veeva Vault RIM applications to streamline clinical execution and improve regulatory management in its animal health business unit.
Another notable achievement for Veeva was the launch of the Veeva AI Partner Program, designed to help partners integrate Generative AI solutions seamlessly with Veeva Vault applications. This initiative highlights Veeva's ongoing efforts to leverage advanced technologies to enhance its product ecosystem. Furthermore, the introduction of Veeva Vault CRM Campaign Manager aims to simplify and speed up non-personal promotion to healthcare professionals, ensuring consistent and compliant marketing efforts.
Financially, Veeva Systems has shown strong performance with its fiscal year 2024 results reflecting robust growth. The company continues to invest in its innovation engine and strategic partnerships, setting the stage for sustained, profitable growth. Veeva's recent financial outlook for fiscal year 2025 and first quarter results for 2024 further underline its market leadership and operational excellence.
For more information about Veeva Systems, its products, and latest updates, visit www.veeva.com.
Emmes has partnered with Veeva Systems (NYSE: VEEV) to standardize on Veeva Development Cloud applications, enhancing speed and compliance in clinical research. This collaboration aims to improve operational efficiency across various functional areas, aiding in the growth of Emmes as it expands into new markets. Veeva's cloud solutions will facilitate better collaboration with sponsors and regulatory compliance. Emmes plans to implement several Veeva applications, thereby establishing a unified technology platform for effective clinical and quality management.
Veeva Systems (NYSE: VEEV) announced the launch of Veeva Vault Validation Management, a new application designed to enhance validation lifecycle management for life sciences companies. This solution streamlines validation processes, reduces manual efforts, and supports electronic execution to improve compliance and efficiency. Veeva Vault Validation Management integrates with other Veeva Vault Quality Suite applications, enabling better documentation and data integrity. The application is expected to be available in the second half of 2022, aiming to optimize quality management across the life sciences value chain.
Veeva Systems (NYSE: VEEV) announced the 2021 Veeva R&D and Quality Summit Connect, featuring keynote speakers from Bristol Myers Squibb, GSK, and Roche. This online event on October 14, 2021, aims to enhance knowledge sharing in life sciences, with over 75 sessions focusing on advancements in digital trials. Industry leaders will discuss operational improvements and compliance strategies. Veeva emphasizes its commitment to innovation and customer success, serving over 1,100 clients.
Veeva Systems (NYSE: VEEV) has announced its 2021 Quality & Regulatory Global Summit, set to begin on October 18, 2021. The virtual summit will feature over 15 sessions with industry leaders from companies like Unilever, BASF, and Estée Lauder. Discussions will focus on modernizing business initiatives including product compliance and sustainability. The event is complimentary for Veeva customers and qualified industry professionals. Veeva, known for its cloud software solutions, aims to support industries like consumer goods and chemicals in overcoming regulatory challenges.
Veeva Systems reported a strong second quarter for fiscal 2022, with total revenues of $455.6 million, marking a 29% year-over-year increase. Subscription services revenues also rose to $366.4 million, up 29%. Operating income was $124.6 million, a 38% increase compared to the prior year. Non-GAAP net income increased by 31% to $152.7 million, with diluted net income per share at $0.67. Veeva's outlook for the third quarter projects revenues between $464 and $466 million and for the fiscal year, between $1,830 and $1,835 million.
Veeva Systems (NYSE: VEEV) announces that B. Braun SE has adopted the Veeva Vault Clinical Operations Suite to enhance clinical study management and payments to partner sites globally. This collaboration aims to improve efficiency and oversight in clinical trials, allowing B. Braun to conduct more studies at a faster pace. The integration includes Veeva's solutions for study management and payments, aiding compliance and reducing administrative burdens. The partnership signifies a step in B. Braun's digital transformation and commitment to advancing healthcare.
Veeva Systems will release its financial results for the second fiscal quarter, concluding on July 31, 2021, after market close on September 1, 2021. A conference call and webcast will be held on the same day at 2:00 p.m. PT (5:00 p.m. ET) to discuss the results. Prepared remarks will be available on Veeva's investor relations website around 1:05 p.m. PT (4:05 p.m. ET). This quarterly release comes as Veeva continues to serve over 1,000 customers globally in the life sciences sector.
Veeva Systems (NYSE: VEEV) announced its acquisition of Learnaboutgmp, a premier provider of accredited GxP training for life sciences, on August 3, 2021. This acquisition combines Learnaboutgmp's extensive eLearning library, featuring over 170 course titles and 450 microlearning assets, with Veeva's Vault Training, enhancing training efficiency and compliance for clients. Learnaboutgmp will continue its operations independently under its founder, maintaining its presence in both Ireland and the United States, while aiming to address growing compliance needs in the industry.
Veeva Systems announced the addition of 11 new therapeutic areas to its customer intelligence platform, Veeva Link, now covering 12 areas including oncology. The platform provides curated expert profiles and real-time insights to enhance engagement between life sciences teams and global experts. Key areas expanded include cardiology, neurology, and respiratory diseases. Veeva aims to set the industry standard in real-time customer intelligence, supporting better research and patient care. A summit on June 10, 2021, will showcase how Veeva Link aids pharma companies in personalizing customer interactions.
Veeva Systems (NYSE: VEEV) announced the upcoming 2021 Veeva Commercial & Medical North America Summit Connect on June 10, 2021, featuring keynotes from industry leaders at Boehringer Ingelheim, GSK, and UCB. The event will explore digital-first engagement and data innovation approaches. Dr. Cecil T. Holbert and Amanda Romano will open with a discussion on evolving healthcare provider access. There will be over 100 sessions focused on transforming commercial strategies in the life sciences sector.
FAQ
What is the current stock price of Veeva Systems (VEEV)?
What is the market cap of Veeva Systems (VEEV)?
What does Veeva Systems Inc. do?
Where is Veeva Systems Inc. headquartered?
What are Veeva's main products?
Who are Veeva Systems' customers?
What recent partnerships has Veeva announced?
What is the Veeva AI Partner Program?
How has Veeva performed financially recently?
What is Veeva Vault CRM Campaign Manager?
What industry does Veeva Systems primarily serve?
How does Veeva contribute to the life sciences industry?
